Arul M. Chinnaiyan

97.6k total citations · 27 hit papers
462 papers, 52.2k citations indexed

About

Arul M. Chinnaiyan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arul M. Chinnaiyan has authored 462 papers receiving a total of 52.2k indexed citations (citations by other indexed papers that have themselves been cited), including 276 papers in Molecular Biology, 168 papers in Cancer Research and 159 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arul M. Chinnaiyan's work include Prostate Cancer Treatment and Research (116 papers), Cancer Genomics and Diagnostics (67 papers) and Cancer-related molecular mechanisms research (53 papers). Arul M. Chinnaiyan is often cited by papers focused on Prostate Cancer Treatment and Research (116 papers), Cancer Genomics and Diagnostics (67 papers) and Cancer-related molecular mechanisms research (53 papers). Arul M. Chinnaiyan collaborates with scholars based in United States, India and Canada. Arul M. Chinnaiyan's co-authors include Vishva M. Dixit, Terrence R. Barrette, Karen O’Rourke, John R. Prensner, Daniel R. Rhodes, Saravana M. Dhanasekaran, Sooryanarayana Varambally, Debashis Ghosh, Scott A. Tomlins and Chandan Kumar‐Sinha and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Arul M. Chinnaiyan

445 papers receiving 51.4k citations

Hit Papers

ONCOMINE: A Cancer Microarray Database and Integrated Dat... 1995 2026 2005 2015 2004 2007 2002 2015 1995 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
    2004 2.8k citations Daniel R. Rhodes, Jianjun Yu et al. profile →
  2. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
    2007 2.4k citations Jindan Yu, Arul M. Chinnaiyan et al. profile →
  3. The polycomb group protein EZH2 is involved in progression of prostate cancer
    2002 2.1k citations Sooryanarayana Varambally, Saravana M. Dhanasekaran et al. profile →
  4. The landscape of long noncoding RNAs in the human transcriptome
    2015 2.1k citations Matthew K. Iyer, Yashar S. Niknafs et al. profile →
  5. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis
    1995 2.0k citations Arul M. Chinnaiyan et al. profile →
  6. Oncomine 3.0: Genes, Pathways, and Networks in a Collection of 18,000 Cancer Gene Expression Profiles
    2007 1.7k citations Daniel R. Rhodes, Jianjun Yu et al. profile →
  7. The Receptor for the Cytotoxic Ligand TRAIL
    1997 1.5k citations Arul M. Chinnaiyan et al. profile →
  8. The Emergence of lncRNAs in Cancer Biology
    2011 1.4k citations John R. Prensner, Arul M. Chinnaiyan profile →
  9. Delineation of prognostic biomarkers in prostate cancer
    2001 1.3k citations Saravana M. Dhanasekaran, Debashis Ghosh et al. profile →
  10. The Landscape of Circular RNA in Cancer
    2019 1.2k citations Sudhanshu Shukla, Saravana M. Dhanasekaran et al. profile →
  11. The Role of Non-coding RNAs in Oncology
    2019 1.1k citations Arul M. Chinnaiyan et al. profile →
  12. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
    2011 815 citations John R. Prensner, Matthew K. Iyer et al. profile →
  13. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
    2004 789 citations Daniel R. Rhodes, Jianjun Yu et al. profile →
  14. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
    2014 737 citations Irfan A. Asangani, Vijaya L. Dommeti et al. profile →
  15. FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis
    1996 653 citations Arul M. Chinnaiyan et al. profile →
  16. Transcriptome sequencing to detect gene fusions in cancer
    2009 631 citations Chandan Kumar‐Sinha, Xuhong Cao et al. profile →
  17. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation
    2010 605 citations Jindan Yu, Arul M. Chinnaiyan et al. profile →
  18. Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95
    1996 556 citations Arul M. Chinnaiyan et al. profile →
  19. Interaction of CED-4 with CED-3 and CED-9: A Molecular Framework for Cell Death
    1997 543 citations Arul M. Chinnaiyan et al. profile →
  20. Molecular Ordering of the Cell Death Pathway
    1996 540 citations Arul M. Chinnaiyan et al. profile →
  21. A Hierarchical Network of Transcription Factors Governs Androgen Receptor-Dependent Prostate Cancer Growth
    2007 524 citations Arul M. Chinnaiyan, Kenneth J. Pienta et al. profile →
  22. Recurrent gene fusions in prostate cancer
    2008 512 citations Chandan Kumar‐Sinha, Scott A. Tomlins et al. profile →
  23. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
    2018 449 citations Paul W. Harms, Pankaj Vats et al. profile →
  24. Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
    2018 384 citations Yi-Mi Wu, Robert J. Lonigro et al. profile →
  25. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
    2015 271 citations Scott A. Tomlins, Robert J. Lonigro et al. profile →
  26. Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response
    2021 199 citations Rahul Mannan, Pankaj Vats et al. profile →
  27. Circular RNA in cancer
    2024 81 citations Arul M. Chinnaiyan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arul M. Chinnaiyan United States 103 37.7k 18.5k 9.9k 8.9k 6.5k 462 52.2k
Benjamin L. Ebert United States 78 46.7k 1.2× 19.4k 1.0× 7.3k 0.7× 10.7k 1.2× 9.5k 1.5× 294 73.5k
Aravind Subramanian United States 29 29.6k 0.8× 9.9k 0.5× 7.1k 0.7× 7.6k 0.8× 7.2k 1.1× 53 45.9k
Scott L. Pomeroy United States 49 27.9k 0.7× 9.8k 0.5× 6.3k 0.6× 6.7k 0.8× 6.3k 1.0× 117 44.5k
Gad Getz United States 74 27.7k 0.7× 18.7k 1.0× 8.1k 0.8× 10.6k 1.2× 5.0k 0.8× 225 42.6k
Chi V. Dang United States 100 38.9k 1.0× 24.2k 1.3× 3.3k 0.3× 9.5k 1.1× 5.2k 0.8× 310 53.3k
William G. Kaelin United States 117 35.6k 0.9× 22.6k 1.2× 6.0k 0.6× 14.8k 1.7× 3.2k 0.5× 246 50.2k
William C. Hahn United States 101 26.5k 0.7× 7.8k 0.4× 4.9k 0.5× 11.2k 1.3× 4.7k 0.7× 293 40.9k
Lance A. Liotta United States 129 34.6k 0.9× 16.9k 0.9× 5.2k 0.5× 16.9k 1.9× 4.4k 0.7× 658 62.1k
Amanda G. Paulovich United States 40 26.0k 0.7× 8.3k 0.4× 5.6k 0.6× 7.0k 0.8× 6.3k 1.0× 87 40.1k
Mien‐Chie Hung United States 138 43.4k 1.2× 13.8k 0.7× 7.7k 0.8× 28.0k 3.1× 8.4k 1.3× 745 67.2k

Countries citing papers authored by Arul M. Chinnaiyan

Since Specialization
Citations

This map shows the geographic impact of Arul M. Chinnaiyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arul M. Chinnaiyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arul M. Chinnaiyan more than expected).

Fields of papers citing papers by Arul M. Chinnaiyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arul M. Chinnaiyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arul M. Chinnaiyan. The network helps show where Arul M. Chinnaiyan may publish in the future.

Co-authorship network of co-authors of Arul M. Chinnaiyan

This figure shows the co-authorship network connecting the top 25 collaborators of Arul M. Chinnaiyan. A scholar is included among the top collaborators of Arul M. Chinnaiyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arul M. Chinnaiyan. Arul M. Chinnaiyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Tiffany M., Yuping Zhang, Javed Siddiqui, et al.. (2025). A simplified MyProstateScore2.0 for high-grade prostate cancer. Cancer Biomarkers. 42(1). 453481555–453481555.
2.
Gajjala, Prathibha R., Yihan Liu, Manjot Bal, et al.. (2024). Discovery of the first selective and potent PROTAC degrader for the pseudokinase TRIB2. European Journal of Medicinal Chemistry. 281. 117016–117016. 3 indexed citations
3.
Ferrari, Marina G., Neetika Khurana, Kristin Juckette, et al.. (2024). Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation. Molecular Cancer Research. 22(9). 826–839. 4 indexed citations
4.
Balikov, Daniel A., Kevin Hu, Bryan L. Betz, et al.. (2021). Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy. International Journal of Molecular Sciences. 22(18). 9992–9992. 8 indexed citations
5.
Singhal, Udit, Yugang Wang, James Henderson, et al.. (2018). Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature. Molecular Cancer Research. 16(4). 643–654. 27 indexed citations
6.
Ekambaram, Prasanna, Dong Hu, Saigopalakrishna S. Yerneni, et al.. (2017). The CARMA3–Bcl10–MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor–Positive Breast Cancer. Cancer Research. 78(5). 1225–1240. 67 indexed citations
7.
Wang, Lisha, Paul W. Harms, Nallasivam Palanisamy, et al.. (2017). Age and Gender Associations of Virus Positivity in Merkel Cell Carcinoma Characterized Using a Novel RNA In Situ Hybridization Assay. Clinical Cancer Research. 23(18). 5622–5630. 26 indexed citations
8.
Asangani, Irfan A., Kari Wilder-Romans, Vijaya L. Dommeti, et al.. (2016). BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer. Molecular Cancer Research. 14(4). 324–331. 127 indexed citations
9.
Harms, Paul W., Pankaj Vats, Monique Verhaegen, et al.. (2015). The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma. Cancer Research. 75(18). 3720–3727. 234 indexed citations
10.
Malik, Rohit, Lalit R. Patel, John R. Prensner, et al.. (2014). The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer. Molecular Cancer Research. 12(8). 1081–1087. 112 indexed citations
11.
Brenner, J. Chad, Felix Y. Feng, Sumin Han, et al.. (2012). PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma. Cancer Research. 72(7). 1608–1613. 206 indexed citations
12.
Mani, Ram S., Matthew K. Iyer, Qi Cao, et al.. (2011). TMPRSS2–ERG-Mediated Feed-Forward Regulation of Wild-Type ERG in Human Prostate Cancers. Cancer Research. 71(16). 5387–5392. 35 indexed citations
13.
Bedolla, Roble, Yu Wang, Karim Chamie, et al.. (2009). Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases. Clinical Cancer Research. 15(3). 788–796. 112 indexed citations
14.
Wang, Rou, David S. Morris, Scott A. Tomlins, et al.. (2009). Development of a Multiplex Quantitative PCR Signature to Predict Progression in Non–Muscle-Invasive Bladder Cancer. Cancer Research. 69(9). 3810–3818. 26 indexed citations
15.
Laxman, Bharathi, David S. Morris, Jianjun Yu, et al.. (2008). A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer. Cancer Research. 68(3). 645–649. 303 indexed citations
16.
Yu, Jindan, Jianjun Yu, Daniel R. Rhodes, et al.. (2007). A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome. Cancer Research. 67(22). 10657–10663. 251 indexed citations
17.
Kim, Jung H., Saravana M. Dhanasekaran, Rohit Mehra, et al.. (2007). Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression. Cancer Research. 67(17). 8229–8239. 88 indexed citations
18.
Abrahamsson, Per‐Anders, Eduardo I. Canto, Arul M. Chinnaiyan, et al.. (2006). Advances in Biomarkers for Prostate Diseases. Lund University Publications (Lund University). 85–85. 1 indexed citations
19.
20.
Ding, Lei, Christine A. Erdmann, Arul M. Chinnaiyan, Sofía D. Merajver, & Celina G. Kleer. (2006). Identification of EZH2 as a Molecular Marker for a Precancerous State in Morphologically Normal Breast Tissues. Cancer Research. 66(8). 4095–4099. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin L. Ebert Breakdown of academic impact, for papers by Aravind Subramanian Breakdown of academic impact, for papers by Scott L. Pomeroy Breakdown of academic impact, for papers by Gad Getz Breakdown of academic impact, for papers by Chi V. Dang Breakdown of academic impact, for papers by William G. Kaelin Breakdown of academic impact, for papers by William C. Hahn Breakdown of academic impact, for papers by Lance A. Liotta Breakdown of academic impact, for papers by Amanda G. Paulovich Breakdown of academic impact, for papers by Mien‐Chie Hung
Rankless by CCL
2026